PT-141

PT-141 in Laboratory Research

PT-141 (bremelanotide) is a cyclic seven-residue analog of alpha-melanocyte-stimulating hormone (alpha-MSH). It behaves as a non-selective melanocortin-receptor agonist, with its strongest affinity at the MC3R and MC4R subtypes, which makes it a defined tool compound for melanocortin-receptor pharmacology.

Research groups keep it on hand as a reference agonist when a well-characterised melanocortin ligand is needed under controlled laboratory conditions.

Research Applications & Study Focus

Studies using PT-141 concentrate on melanocortin-receptor pharmacology and central-nervous-system signalling pathways, where it serves as a defined agonist for probing MC3R- and MC4R-mediated mechanisms in receptor-binding and second-messenger (cAMP) assays.

Reproducible lot specification supports consistent assay conditions across repeated receptor-pharmacology experiments.

Purity, Handling & Verification

Each batch is supplied as a sealed, lyophilized vial and is independently analysed by a third-party laboratory using HPLC and mass spectrometry; the full certificate of analysis is published against its lot number, so results can be verified before use. Store the lyophilized material cool, dry and out of direct light, and reconstitute with bacteriostatic water under standard aseptic laboratory practice.

This material is offered strictly for in vitro laboratory research use only. It is not for human or veterinary consumption, and not for diagnostic or therapeutic use.